Pfizer Inc. (Jobs) Profit Falls on Charge to “Exit” Exubera

NEW YORK, Oct 18 (Reuters)- Pfizer Inc. (PFE.N: Quote, Profile, Research) said on Thursday third-quarter earnings fell sharply, hurt by a $2.8 billion charge to end its involvement with its poorly-selling Exubera inhaled insulin drug.